Evidence map›Paper›PMID 34803913›Full record

Trial reportFrontiers in endocrinology2021

Quercetin Modulates IGF-I and IGF-II Levels After Eccentric Exercise-Induced Muscle-Damage: A Placebo-Controlled Study.

Paolo Sgrò, Roberta Ceci, Marco Lista, Federica Patrizio, Stefania Sabatini, Francesco Felici, Massimo Sacchetti, Ilenia Bazzucchi, Guglielmo Duranti, Luigi Di Luigi

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Frontiers in endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. The Effect ofAntioxidants (Basel, Switzerland) · 2024
    Article
  10. Review
  11. Comparative Metabolomic Analysis ofInternational journal of molecular sciences · 2024
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Paolo SgròEndocrinology Unit - Department of Movement, Human and Health Sciences, Università degli Studi di Roma "Foro Italico", Roma, Italy.
Roberta CeciLaboratory of Biochemistry of Movement - Department of Movement, Human and Health Sciences, Università degli Studi di Roma "Foro Italico", Roma, Italy.
Marco ListaEndocrinology Unit - Department of Movement, Human and Health Sciences, Università degli Studi di Roma "Foro Italico", Roma, Italy.
Federica PatrizioLaboratory of Exercise Physiology - Department of Movement, Human and Health Sciences, Università degli Studi di Roma "Foro Italico", Roma, Italy.
Stefania SabatiniLaboratory of Biochemistry of Movement - Department of Movement, Human and Health Sciences, Università degli Studi di Roma "Foro Italico", Roma, Italy.
Francesco FeliciLaboratory of Exercise Physiology - Department of Movement, Human and Health Sciences, Università degli Studi di Roma "Foro Italico", Roma, Italy.
Massimo SacchettiLaboratory of Exercise Physiology - Department of Movement, Human and Health Sciences, Università degli Studi di Roma "Foro Italico", Roma, Italy.
Ilenia BazzucchiLaboratory of Exercise Physiology - Department of Movement, Human and Health Sciences, Università degli Studi di Roma "Foro Italico", Roma, Italy.
Guglielmo DurantiLaboratory of Biochemistry of Movement - Department of Movement, Human and Health Sciences, Università degli Studi di Roma "Foro Italico", Roma, Italy.
Luigi Di LuigiEndocrinology Unit - Department of Movement, Human and Health Sciences, Università degli Studi di Roma "Foro Italico", Roma, Italy.
Foro Italico University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Prolonged or unaccustomed eccentric exercise may cause muscle damage and depending from its extent, this event negatively affects physical performance. Objectives: The aim of the present investigation was to evaluate, in humans, the effect of the flavonoid quercetin on circulating levels of the anabolic insulin-like growth factor 1 (IGF-I) and insulin-like growth factor 2 (IGF-II), produced during the recovery period after an eccentric-induced muscle damage (EIMD). Methods: A randomized, double-blind, crossover study has been performed; twelve young men ingested quercetin (1 g/day) or placebo for 14 days and then underwent an eccentric-induced muscle damaging protocol. Blood samples were collected, and cell damage markers [creatine kinase (CK), lactate dehydrogenase (LDH) and myoglobin (Mb)], the inflammatory responsive interleukin 6 (IL-6), IGF-I and IGF-II levels were evaluated before the exercise and at different recovery times from 24 hours to 7 days after EIMD. Results: We found that, in placebo treatment the increase in IGF-I (72 h) preceded IGF-II increase (7 d). After Q supplementation there was a more marked increase in IGF-I levels and notably, the IGF-II peak was found earlier, compared to placebo, at the same time of IGF-I (72 h). Quercetin significantly reduced plasma markers of cell damage [CK (p<0.005), LDH (p<0.001) and Mb (p<0.05)] and the interleukin 6 level [IL-6 (p<0.05)] during recovery period following EIMD compared to placebo. Conclusions: Our data are encouraging about the use of quercetin as dietary supplementation strategy to adopt in order to mitigate and promote a faster recovery after eccentric exercise as suggested by the increase in plasma levels of the anabolic factors IGF-I and IGF-II.

Indexed as

AdolescentAdultCross-Over StudiesDouble-Blind MethodExerciseHumansInsulin-Like Growth Factor IInsulin-Like Growth Factor IIItalyMaleMuscle, SkeletalMuscle StrengthQuercetinRange of Motion, ArticularYoung AdultIGF1 protein, humanIGF2 protein, humanInsulin-Like Growth Factor IInsulin-Like Growth Factor IIQuercetinanabolic factorsanti-inflammatoryantioxidanteccentric exerciseskeletal muscle mass recovery

Identifiers

PMID34803913
PMCPMC8595302
OpenAlexW3208193902

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.